HC-X029

N/A

Report date: 2024/07/05 10:51:03
NME

Base Information

Drug NameHC-X029
Drug Alias NameHC-X029HCX-029HC-4955
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen receptor splice variant 7 degraders
TargetsAndrogen receptor splice variant 7
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHinova Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesHinova Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A